| Mr Thomas Kelton Bullock Jr, RPH | |
|
703 N Mckenzie St, Foley, AL 36535-3542 | |
| (251) 200-5750 | |
| (251) 200-5725 |
| Full Name | Mr Thomas Kelton Bullock Jr |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 703 N Mckenzie St, Foley, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366706186 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | D07327 (Mississippi) | Secondary |
| 183500000X | Pharmacist | 17582 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Thomas Kelton Bullock Jr, RPH 10097 Grove Dr, Fairhope, AL 36532-5777 Ph: (228) 216-2501 | Mr Thomas Kelton Bullock Jr, RPH 703 N Mckenzie St, Foley, AL 36535-3542 Ph: (251) 200-5750 |
News Archive
The European Centre has been mandated since 2002 to undertake follow-up activities of the "Madrid International Plan of Action on Ageing" (MIPPAA). The work had been undertaken with a formal collaboration and the assistance of the UNECE, Geneva.
Conceptus, Inc., developer of the Essure® procedure, the first proven non-incisional permanent birth control method available, today announced that the United Stated District Court, Northern District of California has denied Conceptus' motion for a preliminary injunction prohibiting Hologic, Inc. from importing, using, selling or offering to sell the Adiana system in the United States.
Numerous studies have shown that physical exercise seems beneficial in the prevention of cognitive impairment and dementia in old age. Now researchers at Goethe University Frankfurt have explored in one of the first studies worldwide how exercise affects brain metabolism.
Precision BioSciences, today announced that it has been awarded over $3 million across four government grants. These grants were each awarded to Precision during the 4th Quarter of 2010 and came from the National Institute of Standards and Technology, the Treasury Department, the National Institute of Health, and the State of North Carolina.
Hyperion Therapeutics today announced that the first patient has been enrolled in a clinical trial of investigational compound HPN-100 (glycerol phenylbutyrate) in children ages 6-17 with urea cycle disorders (UCD). The study will evaluate the safety, tolerability, and ammonia control of glycerol phenylbutyrate compared to BUPHENYL® (sodium phenylbutyrate).
› Verified 2 days ago
Glenn M Hanson, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1255 S Mckenzie St, Foley, AL 36535 Phone: 850-462-9555 | |
Vivian Waller, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 110 E Azalea Ave, Foley, AL 36535 Phone: 251-424-1563 | |
Dr. Carrie Renee Williams Ray, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2200 S Mckenzie St, Foley, AL 36535 Phone: 251-943-3320 Fax: 251-943-3327 | |
David Carl Latiolais, DPH,RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1255 S Mckenzie St, Foley, AL 36535 Phone: 251-943-1588 | |
Kathleen Elise Dismukes, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 698 S Mckenzie St, Foley, AL 36535 Phone: 251-971-6258 | |
Mrs. Patricia A Sanders, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1235 S Mckenzie St, Foley, AL 36535 Phone: 251-943-4722 Fax: 251-943-8722 | |
Mr. Burke Ernest Langham Jr., RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1300 S Mckenzie St, Foley, AL 36535 Phone: 251-943-6614 Fax: 251-943-6615 |